Fortrea Holdings (FTRE) Cash from Investing Activities (2022 - 2026)

Fortrea Holdings (FTRE) reported Cash from Investing Activities of -$8.0 million for Q1 2026, down 149.69% on a YoY basis from $16.1 million in Q1 2025, and down 6.67% quarter-over-quarter from -$7.5 million in Q4 2025.

Fortrea Holdings (FTRE) Cash from Investing Activities (2022 - 2026) Analysis & Trends

Fortrea Holdings has reported Cash from Investing Activities for 5 years, with the latest figure at -$8.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Investing Activities fell 149.69% year-over-year to -$8.0 million; the trailing twelve-month figure through Mar 2026 stood at -$9.7 million (down 103.5% YoY), and the FY2025 full-year result was $14.4 million, down 94.28% from the prior year.
  • Cash from Investing Activities for Q1 2026 stood at -$8.0 million, down from -$7.5 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $265.4 million in Q2 2024, with the low at -$18.4 million in Q4 2022.
  • Historically, Cash from Investing Activities has averaged $12.7 million across 5 years, with a median of -$8.0 million in 2026.
  • The largest YoY upside for Cash from Investing Activities was 2953.76% in 2024 against a maximum downside of 400.0% in 2024.
  • Fortrea Holdings' Cash from Investing Activities stood at -$18.4 million in 2022, then jumped by 51.09% to -$9.0 million in 2023, then soared by 138.89% to $3.5 million in 2024, then sank by 314.29% to -$7.5 million in 2025, then slipped by 6.67% to -$8.0 million in 2026.
  • The last three Cash from Investing Activities figures came in at -$8.0 million (Q1 2026), -$7.5 million (Q4 2025), and $13.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.89 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 638.50 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -431.90 Mn
9 Abivax 91.96 Bn 91.96 Bn - 579,519.10
10 Fortrea Holdings 1.43 Bn 1.28 Bn 123.60 Mn -8.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -8.00 Mn
Mar 31, 2026 -8.00 Mn
Dec 31, 2025 -7.50 Mn
Dec 31, 2025 -7.50 Mn
Sep 30, 2025 13.30 Mn
Sep 30, 2025 13.30 Mn
Jun 30, 2025 -7.50 Mn
Jun 30, 2025 -7.50 Mn
Mar 31, 2025 16.10 Mn
Mar 31, 2025 16.10 Mn
Dec 31, 2024 3.50 Mn
Dec 31, 2024 3.50 Mn
Sep 30, 2024 -8.10 Mn
Sep 30, 2024 -8.10 Mn
Jun 30, 2024 265.40 Mn
Jun 30, 2024 265.40 Mn
Mar 31, 2024 -9.20 Mn
Mar 31, 2024 -9.20 Mn
Dec 31, 2023 -9.00 Mn
Dec 31, 2023 -9.00 Mn